Identification of the Molecular Partners of Lymphocyte Phosphatase-Associated Phosphoprotein (LPAP) That Are Involved in Human Lymphocyte Activation
- Авторлар: Kruglova N.A.1,2, Kopylov A.T.3, Filatov A.V.1,2
-
Мекемелер:
- Institute of Immunology National Research Center, Federal Medical-Biological Agency
- Immunology Department, Biological Faculty, Moscow State University
- Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences
- Шығарылым: Том 53, № 5 (2019)
- Беттер: 739-747
- Бөлім: Molecular Mechanisms of Adaptive Immunity
- URL: https://journals.rcsi.science/0026-8933/article/view/164072
- DOI: https://doi.org/10.1134/S002689331905011X
- ID: 164072
Дәйексөз келтіру
Аннотация
Lymphocyte phosphatase-associated phosphoprotein (LPAP) is a small transmembrane protein that is found in lymphocytes and is tightly associated with the phosphatase CD45. The function of LPAP is still unknown. Studies of the LPAP interactome may reveal new details of how C45 and lymphocyte signaling in general are regulated. LPAP binding partners were sought using coimmunoprecipitation coupled with mass spectrometry, stabilization of protein complexes with chemical crosslinkers, and Blue Native electrophoresis. In addition to CD45, several proteins were identified as LPAP partners, including CD71, CD98, cytoskeletal proteins, the amino acid transporter SLC1A4, and the cell signaling component HS1. It was confirmed that more than 70% of LPAP molecules were bound with CD45 in a 1 : 1 complex. The effect of CD45 on LPAP was studied in CEM and Jurkat cells with a CD45 knockout. The LPAP levels in the cells were 10% of the level in wild-type cells. In the absence of CD45, LPAP phosphorylation at Ser-153 and Ser-163 was not affected, whereas phosphorylation at Ser-99 and Ser-172 decreased significantly. Based on the results, CD45 was assumed to play a role in regulating LPAP expression and phosphorylation status.
Негізгі сөздер
Авторлар туралы
N. Kruglova
Institute of Immunology National Research Center, Federal Medical-Biological Agency; Immunology Department, Biological Faculty, Moscow State University
Хат алмасуға жауапты Автор.
Email: natalya.a.kruglova@yandex.ru
Ресей, Moscow, 115522; Moscow, 119234
A. Kopylov
Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences
Email: natalya.a.kruglova@yandex.ru
Ресей, Moscow, 119121
A. Filatov
Institute of Immunology National Research Center, Federal Medical-Biological Agency; Immunology Department, Biological Faculty, Moscow State University
Email: natalya.a.kruglova@yandex.ru
Ресей, Moscow, 115522; Moscow, 119234
Қосымша файлдар
